HerbParlor
Lemon Balm (Melissa officinalis L.)Emerging evidence

Lemon Balm

Melissa officinalis L.

Overview

At a glance

Lemon Balm is Melissa officinalis L., a Lamiaceae botanical used traditionally and in contemporary herbal preparations. Human evidence has signals around anxiety/stress, sleep and cognition, but the evidence is heterogeneous and highly preparation-dependent.

Key takeaway

Lemon Balm is not one uniform intervention: species identity, plant part, preparation (tea/infusion, dried herb or powder, oral extract) and whether the product is a whole-leaf preparation or a standardized/specialized extract all matter when interpreting research.

Common uses studied

Traditional herbal useAnxiety/stress researchSleep researchCognition researchCommercial Lemon Balm preparations

Start here

What are you trying to figure out?

Pick the question closest to yours. Each card jumps to the relevant part of this profile or an existing HerbParlor tool — no sponsored rankings, no hidden ordering.

Understand the herbExplore the evidenceUnderstand formsCheck safetyEvaluate a supplementCompare options

Identity

What is this herb?

Family

Lamiaceae

Species

Melissa officinalis L.

Common names

Lemon BalmMelissaBalmCommon balmSweet balm

Plant parts used

Leaf

Geographic context

Kew records Melissa officinalis L. as native to southern Europe and the Mediterranean region, widely cultivated elsewhere.

Identification notes

This profile refers to the accepted species Melissa officinalis L. No separate canonical entity is created for Melissa or Melissa leaf; both refer to the same species and the same canonical herb. Unrelated botanicals should not be treated as equivalent.

Background

Traditional context

Traditions

European herbal-medicine context

Historical uses

Traditional use of Melissa officinalis leaf preparationsHistorical use related to calm, sleep and digestive comfort

Traditional use and regulatory recognition provide historical or regulatory context and should not be treated as proof of clinical efficacy.

Preparations

Forms & preparations

Forms

Dried leafLeaf powderTea / infusionLiquid extract / tinctureDry extractCapsuleTabletStandardized or specialized extract

Preparation methods

Hot-water infusion (tea)Dried and powdered leaf materialEthanolic or other liquid extractionDry extract preparationStandardized or specialized extraction where explicitly disclosed

What changes between forms

  • A tea/infusion, a dried-leaf powder and a concentrated extract are not automatically equivalent preparations.
  • Ordinary leaf preparations and standardized or specialized extracts should be distinguished; evidence for one should not automatically be generalized to the other.
  • A standardized extract characterized by a marker compound (such as rosmarinic acid) or a specialized delivery form (such as a phytosome) is a specific preparation and not interchangeable with every Lemon Balm product.
  • Combination formulas should not automatically be treated as evidence for Lemon Balm alone.

Human studies have used different Melissa officinalis preparations, including teas, leaf extracts and standardized or specialized extracts. Findings from a specific preparation should not automatically be generalized to every Lemon Balm product.

Research

Research Explorer

Each question summarizes what human research has examined, how it was studied, and the main limitations — not a treatment recommendation.

What does human evidence suggest about Lemon Balm and anxiety or stress?

Population

Adults studied for anxiety-, stress- or mood-related outcomes in clinical trials and reviews of Melissa officinalis preparations.

Intervention

Melissa officinalis preparations, including leaf extracts and teas where specified.

Comparator

Placebo or control interventions where used.

Outcomes studied

Anxiety symptomsStress-related measuresMoodSelf-reported calm

Evidence assessment

A 2021 systematic review and meta-analysis reported signals for anxiety and depression-related outcomes, but the evidence is limited by a small number of trials and substantial heterogeneity. Findings do not establish Lemon Balm as a proven treatment for anxiety or any anxiety disorder.

Limitations

  • Small number of trials
  • Substantial heterogeneity across studies
  • Different preparations, doses and outcome measures
  • Findings should not be generalized to every commercial product

Sources

What does human evidence suggest about Lemon Balm and sleep?

Population

Adults studied for sleep-related outcomes in clinical research on Melissa officinalis preparations.

Intervention

Melissa officinalis preparations, including a specific standardized Melissa officinalis phytosome where studied.

Comparator

Placebo or control interventions where used.

Outcomes studied

Sleep qualitySleep-related measuresSelf-reported rest

Evidence assessment

A specific standardized Melissa officinalis phytosome has been studied for sleep outcomes. This evidence is preparation-specific and should not be generalized to every Lemon Balm product. Broader sleep evidence remains limited and heterogeneous.

Limitations

  • Preparation-specific evidence (phytosome) does not apply to every Lemon Balm product
  • Limited and heterogeneous broader sleep evidence
  • Different preparations and outcome measures

Sources

What does human research say about Lemon Balm and cognition?

Population

Older adults without dementia studied in a randomized controlled trial of a Melissa officinalis extract containing rosmarinic acid, plus adults in broader cognition research.

Intervention

Melissa officinalis extracts, including a rosmarinic-acid-containing extract where specified.

Comparator

Placebo or control interventions where used.

Outcomes studied

Cognitive-function measuresMemoryAttention

Evidence assessment

A randomized controlled trial examined a Melissa officinalis extract containing rosmarinic acid in older adults without dementia. These cognition findings should not be generalized to dementia treatment or prevention. Broader cognition evidence remains limited and preparation-dependent.

Limitations

  • Cognition findings should not be generalized to dementia treatment or prevention
  • Preparation-specific evidence does not apply to every Lemon Balm product
  • Limited and heterogeneous broader cognition evidence

Sources

How preparation-specific are the clinical findings?

Population

People comparing commercial Lemon Balm products with the preparations studied in human research.

Intervention

Different Melissa officinalis preparations (tea, leaf powder, extracts, standardized or specialized extracts).

Comparator

Not applicable.

Outcomes studied

Preparation identityEvidence interpretability

Evidence assessment

Clinical findings are highly preparation-dependent. A tea, a leaf powder, a dry extract and a standardized or specialized extract may differ in composition and should not be treated as interchangeable interventions.

Limitations

  • Commercial labels may omit preparation details
  • Studies do not use one uniform Melissa officinalis intervention
  • Standardization is not consistently disclosed or comparable

Sources

How heterogeneous is the evidence base?

Population

Adults represented across the available Melissa officinalis human clinical literature.

Intervention

Melissa officinalis preparations studied in human research.

Comparator

Varies by study and review.

Outcomes studied

Clinical outcomesBiomarkersStudy certainty and limitations

Evidence assessment

The human evidence base is heterogeneous, with variation in preparations, doses, durations, populations and outcome measures. Certainty is often limited, and findings should be interpreted at the level of the preparation and outcome studied.

Limitations

  • Small number of trials in several syntheses
  • Substantial heterogeneity
  • Risk of overinterpreting surrogate or self-reported outcomes
  • Limited ability to infer effects for commercial products

Sources

What changes between tea, leaf powder and standardized extracts?

Population

People comparing Melissa officinalis food products and commercial preparations with human research interventions.

Intervention

Tea/infusion, dried leaf powder, liquid or dry extracts, and standardized or specialized extracts.

Comparator

Different Melissa officinalis preparations.

Outcomes studied

Preparation identityAmount disclosedEvidence interpretabilitySafety context

Evidence assessment

Preparation is central to interpretation. A tea, a leaf powder, a concentrated extract and a standardized or specialized extract may differ in composition and amount; evidence for one should not automatically be applied to another.

Limitations

  • Commercial labels may omit preparation details
  • Studies do not use one uniform Melissa officinalis intervention
  • Standardization is not consistently disclosed or comparable

Sources

Latest evidence

Recently published research

Searching Europe PMC…

Looking for recent publications…

These publications are automatically discovered from Europe PMC. They have not necessarily been independently reviewed by HerbParlor and are not automatically incorporated into the evidence assessment.

Evidence

Evidence

Human research on Melissa officinalis includes trials and reviews of anxiety/stress, sleep and cognition outcomes. There are signals of effect, but the evidence is heterogeneous and highly preparation-dependent. Current evidence does not establish Lemon Balm as a proven treatment for anxiety, insomnia, dementia or any other disease.

Evidence tier

Emerging

Confidence

Overall confidence is emerging but limited. The main uncertainties concern preparation, dose, duration, study quality, sample size and outcome selection. Evidence from a specific preparation should not automatically be generalized to every Lemon Balm product.

Last evidence review

2026-09-20

Where the evidence is strongest

Preparation-aware synthesis of emerging human anxiety/stress, sleep and cognition researchIdentification of consistent limitations across small and heterogeneous studies

How to interpret this

Lemon Balm evidence should be interpreted at the level of the identified species, plant part, preparation, amount and outcome studied. The current human literature is emerging and heterogeneous; it does not justify broad therapeutic claims or dosage recommendations.

Automatic evidence update

Since the last editorial review

Checking Europe PMC…
Checking evidence

Checking for publications published since the last editorial evidence review…

This automatic update detects newly published literature; it does not replace HerbParlor's editorial evidence assessment. Review status is an automatic triage signal. Curated HerbParlor evidence is unchanged until editorial review.

Boundaries

What the evidence does NOT establish

Areas with limited evidence

  • Broad claims about anxiety, sleep or cognition
  • Generalization across teas, leaf powders and standardized or specialized extracts
  • Long-term clinical outcomes and safety of concentrated extracts
  • Translation from laboratory or preclinical findings to patient-important outcomes

Evidence gaps

  • Larger, longer and well-described randomized trials
  • Direct comparisons of tea, leaf powder and standardized or specialized extracts
  • Consistent reporting of preparation, amount and marker-compound characteristics
  • Independent confirmation of clinically meaningful outcomes

Common misconceptions

  • A Lemon Balm tea and a concentrated extract are interchangeable preparations.
  • Traditional use of Lemon Balm is equivalent to clinical proof of efficacy.
  • Evidence from one studied extract automatically applies to every Lemon Balm product.
  • Laboratory or preclinical evidence is equivalent to human clinical efficacy.
  • A higher extract amount automatically means a stronger or better product.
  • Cognition findings in adults without dementia establish Lemon Balm as a dementia treatment or preventive.
  • A combination product provides the same evidence as Lemon Balm alone.
  • A standardized or specialized extract is automatically equivalent to an ordinary leaf preparation.

Safety

Safety & interactions

General considerations

  • Lemon Balm has been described as generally well tolerated for short-term use in traditional and clinical contexts, but long-term safety evidence is limited and safety should be interpreted according to the specific preparation, amount and duration studied.
  • Absence of a reported problem in one study should not be generalized to every Lemon Balm product, particularly concentrated or specialized extracts.

Pregnancy & nursing

  • Pregnancy and breastfeeding safety information is limited; use should not be assumed to be safe for every preparation.
  • People who are pregnant or breastfeeding should discuss a specific product with a qualified healthcare professional.

Medication interactions to be aware of

The available sources do not establish a complete interaction profile for every Melissa officinalis preparation. People taking medicines, particularly sedatives or other agents where interaction information is uncertain, should discuss a specific product with a qualified healthcare professional rather than infer safety from traditional use.

Condition considerations

  • People with medical conditions or people taking medicines should discuss use with a healthcare professional rather than assuming Lemon Balm is appropriate.
  • Uncertainty is greater when a product does not identify its plant part, preparation or amount.

Duration

  • Long-term safety of concentrated Melissa officinalis extracts is not well established by the available sources.

Talk to a healthcare professional if any apply

  • Pregnancy or breastfeeding
  • Use of prescription medicines, particularly sedatives
  • Persistent or unexplained symptoms
  • Use of a concentrated or specialized extract with unclear composition
  • Significant or unexpected adverse effects

Products

What changes between products?

Form differences

  • A tea/infusion, a dried-leaf powder and a concentrated extract are not automatically equivalent preparations.
  • Ordinary leaf preparations and standardized or specialized extracts should be distinguished; evidence for one should not automatically be generalized to the other.
  • A standardized extract characterized by a marker compound (such as rosmarinic acid) or a specialized delivery form (such as a phytosome) is a specific preparation and not interchangeable with every Lemon Balm product.
  • Combination formulas should not automatically be treated as evidence for Lemon Balm alone.

Form considerations

  • Tea, leaf powder, liquid extract and dry extract can represent different amounts and preparations.
  • Do not compare products solely by package size or headline Lemon Balm weight.

Plant part considerations

  • Confirm which Melissa officinalis plant part is used.
  • Do not treat unrelated botanical materials as automatically equivalent.

Extract considerations

  • Record extract characteristics only when the product source explicitly provides them.
  • Do not infer an extraction ratio, concentration or clinical equivalence from a label that does not provide it.

Standardization considerations

  • Record declared standardization only when genuinely disclosed.
  • Do not invent a preferred marker-compound threshold or extraction ratio.
  • Do not imply that a standardized product is automatically more effective.

Evaluation

How to evaluate a supplement

What to check

  • Melissa officinalis species identity
  • Plant part, such as leaf, where disclosed
  • Tea/infusion, leaf powder, extract or other preparation
  • Amount per serving and serving information
  • Extract characteristics where explicitly disclosed
  • Standardization only where genuinely disclosed
  • Marker compound (such as rosmarinic acid) only where explicitly disclosed
  • Whether the product is Lemon Balm alone or a combination formula
  • Other ingredients and label transparency
  • Identity, contaminant and batch testing where disclosed

Serving considerations

  • Compare the labelled amount and preparation with the intervention used in the relevant research without inventing a dosage recommendation.
  • A larger declared amount does not automatically mean a stronger or better-supported product.

Testing considerations

  • Look for species and plant-part identity testing where disclosed.
  • Look for contaminant testing and batch or lot traceability where disclosed.
  • Treat testing information as a product-quality disclosure, not as proof of clinical efficacy.

Label transparency

  • The species should be identifiable where possible.
  • The plant part and preparation should be clear.
  • The amount per serving should be explicit.
  • Combination ingredients should be listed.
  • Extract or standardization claims should be specific and sourceable.
  • Marketing language should not be treated as human clinical evidence.

Supplements

Related supplements

Sources

Authoritative sources referenced

research-reviewedLast reviewed 2026-09-20Next review 2027-09-20

Sections reviewed

overviewbotanicaltraditionalContextpreparationsresearchevidencesafetyproductEvaluationrelationshipssources

Created the Lemon Balm Herb Profile v1 with botanical identity, separate traditional-use context, preparation-aware human evidence across anxiety/stress, sleep and cognition, cautious safety framing, product-evaluation criteria and auditable review metadata.

This profile is provided for educational purposes only and is not medical advice. Traditional context and research summaries are distinguished from claims, and nothing here is a treatment recommendation. Always consult a qualified healthcare professional before using any herb, especially if you are pregnant, nursing, take medication, or have a medical condition.